Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$493K Buy
+30,300
New +$540K ﹤0.01% 4780
2025
Q4
Sell
-157,800
Closed -$2.97M 6530
2025
Q3
$2.97M Buy
+157,800
New +$2.83M ﹤0.01% 3676
2023
Q3
Sell
-11,800
Closed -$277K 6641
2023
Q2
$277K Sell
11,800
-1,900
-14% -$32.2K ﹤0.01% 4942
2023
Q1
$163K Buy
+13,700
New +$195K ﹤0.01% 5257
2022
Q4
Sell
-63,900
Closed -$1.22M 7121
2022
Q3
$1.22M Buy
+63,900
New +$1.27M ﹤0.01% 4174
2022
Q2
Sell
-20,000
Closed -$602K 7583
2022
Q1
$602K Buy
+20,000
New +$624K ﹤0.01% 4976

Other funds holding XP

Israel Englander's XP Position: Q2 2026 in Review

Israel Englander increased its XP (XP) stake by 365% in Q2 2026, buying an estimated $3.09M and bringing the position to 221,187 shares worth $3.6M. The position accounts for ﹤0.01% of the portfolio, ranked #3310.

Israel Englander first reported a position in XP in Q4 2019 and has held it in 27 quarters since. The position peaked at $111M in Q2 2024. 319 funds tracked by Wall St. Rank hold XP as of Q2 2026.

  • Israel Englander held 221,187 shares of XP worth $3.6M as of Q2 2026.
  • Israel Englander bought 173,595 XP shares in Q2 2026, an estimated $3.09M.
  • XP made up ﹤0.01% of Israel Englander's portfolio in Q2 2026, its #3310 holding.
  • Israel Englander first reported a position in XP in Q4 2019 and has held it in 27 quarters since.
  • Israel Englander's XP position peaked at $111M in Q2 2024.
  • 319 funds tracked by Wall St. Rank held XP as of Q2 2026.

Based on Millennium Management's 13F filing for Q2 2026, filed 14 Aug 2026.